☰

Brit B. Turnbull, Ph.D. - Publications

Affiliations: 
2007 Stanford University, Palo Alto, CA 
Area:
Statistics
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Scandling JD, Busque S, Shizuru JA, Lowsky R, Hoppe R, Dejbakhsh-Jones S, Jensen K, Shori A, Strober JA, Lavori P, Turnbull BB, Engleman EG, Strober S. Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 695-704. PMID 25693475 DOI: 10.1111/Ajt.13091  0.469
2014 Scandling J, Busque S, Shizuru J, Lowsky R, Dejbakhsh-Jones S, Jensen K, Shori A, Turnbull B, Engleman E, Strober S. Tolerance, Mixed Chimerism, and Graft Survival in HLA Matched and Mismatched Recipients of Kidney and Hematopoietic Cell Transplants. Transplantation. 98: 901. DOI: 10.1097/00007890-201407151-03081  0.439
2010 Logan AC, Turnbull BB, Lavori PW, Miklos DB, Negrin RS, Lowsky R, Kohrt HE. Assessment Of The Utility Of Subset Donor Chimerism For Predicting Event-Free Survival After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using TLI And ATG Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.351  0.425
2009 Kohrt HE, Turnbull BB, Heydari K, Shizuru JA, Laport GG, Miklos DB, Johnston LJ, Arai S, Weng WK, Hoppe RT, Lavori PW, Blume KG, Negrin RS, Strober S, Lowsky R. TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood. 114: 1099-109. PMID 19423725 DOI: 10.1182/Blood-2009-03-211441  0.499
2008 Kohrt H, Turnbull B, Laport G, Miklos D, Shizuru J, Johnston L, Arai S, Weng WK, Benjamin J, Blume K, Negrin R, Lavori P, Strober S, Lowsky R. Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity Blood. 112: 3310-3310. DOI: 10.1182/Blood.V112.11.3310.3310  0.478
Show low-probability matches.